Cargando…
Empagliflozin Inhibits Basal and IL-1β-Mediated MCP-1/CCL2 and Endothelin-1 Expression in Human Proximal Tubular Cells
SGLT2 inhibitors (SGLT2i) slow the progression of chronic kidney disease; however, evidence for the underlying molecular mechanisms is scarce. We investigated SGLT2i-mediated effects on differential gene expression in two independent human proximal tubular cell (HPTC) lines (HK-2 and RPTEC/TERT1) at...
Autores principales: | Pirklbauer, Markus, Bernd, Maximilian, Fuchs, Lisa, Staudinger, Petra, Corazza, Ulrike, Leierer, Johannes, Mayer, Gert, Schramek, Herbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7663377/ https://www.ncbi.nlm.nih.gov/pubmed/33139635 http://dx.doi.org/10.3390/ijms21218189 |
Ejemplares similares
-
Empagliflozin Inhibits IL-1β-Mediated Inflammatory Response in Human Proximal Tubular Cells
por: Pirklbauer, Markus, et al.
Publicado: (2021) -
Synergistic induction of CCL2/MCP-1 expression driven by oncostatin M and IL-1β in human proximal tubular cells depends on STAT3 and p65 NFκB/RelA
por: Sarközi, Rita, et al.
Publicado: (2015) -
Anti-inflammatory potential of Empagliflozin
por: Pirklbauer, Markus
Publicado: (2021) -
CCL2/MCP-1 modulation of microglial activation and proliferation
por: Hinojosa, Ara E, et al.
Publicado: (2011) -
Proteolytic processing and inactivation of CCL2/MCP-1 by meprins
por: Herzog, Christian, et al.
Publicado: (2016)